⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for regional neuroblastoma

Every month we try and update this database with for regional neuroblastoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Combination Chemotherapy or Observation Following Surgery in Treating Infants With NeuroblastomaNCT00002803
Neuroblastoma
cyclophosphamid...
doxorubicin hyd...
vincristine sul...
conventional su...
- 1 YearNational Cancer Institute (NCI)
Biomarkers in Samples From Young Patients With NeuroblastomaNCT01358604
Neuroblastoma
polymerase chai...
protein express...
western blottin...
flow cytometry
immunohistochem...
laboratory biom...
- 120 YearsChildren's Oncology Group
Combination Chemotherapy in Treating Children With NeuroblastomaNCT00003093
Neuroblastoma
filgrastim
sargramostim
carboplatin
cyclophosphamid...
doxorubicin hyd...
etoposide
conventional su...
neoadjuvant the...
- 20 YearsChildren's Oncology Group
Genetic Analysis Using Blood or Bone Marrow From Participants With Neuroblastoma or Noncancerous ConditionsNCT00436696
Localized Resec...
Localized Unres...
Recurrent Neuro...
Regional Neurob...
Stage 4 Neurobl...
Laboratory Biom...
- Children's Oncology Group
Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk NeuroblastomaNCT00567567
Localized Resec...
Localized Unres...
Recurrent Neuro...
Regional Neurob...
Stage 4 Neurobl...
Stage 4S Neurob...
Autologous Hema...
Carboplatin
Cisplatin
Cyclophosphamid...
Doxorubicin Hyd...
Etoposide
External Beam R...
Filgrastim
Isotretinoin
Laboratory Biom...
Melphalan
Peripheral Bloo...
Pharmacological...
Thiotepa
Topotecan Hydro...
Vincristine Sul...
- 30 YearsChildren's Oncology Group
Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With NeuroblastomaNCT00033293
Localized Resec...
Localized Unres...
Regional Neurob...
Stage 4 Neurobl...
Stage 4S Neurob...
Clinical Observ...
Cyclophosphamid...
Laboratory Biom...
Magnetic Resona...
Prednisone
Therapeutic Imm...
- 8 YearsChildren's Oncology Group
Observation, Combination Chemotherapy, Radiation Therapy, and/or Autologous Stem Cell Transplant in Treating Young Patients With NeuroblastomaNCT00410631
Neuroblastoma
filgrastim
carboplatin
cisplatin
cyclophosphamid...
dacarbazine
doxorubicin hyd...
etoposide phosp...
ifosfamide
isotretinoin
melphalan
topotecan hydro...
vincristine sul...
vindesine
autologous hema...
conventional su...
peripheral bloo...
iobenguane I 13...
radiation thera...
- 21 YearsNational Cancer Institute (NCI)
Carboplatin and Vincristine Plus Radiation Therapy Followed By Adjuvant Chemotherapy in Treating Young Patients With Newly Diagnosed CNS Embryonal TumorsNCT00003203
Brain Tumors
Central Nervous...
Neuroblastoma
filgrastim
carboplatin
cisplatin
cyclophosphamid...
vincristine sul...
adjuvant therap...
radiation thera...
3 Years - 21 YearsChildren's Oncology Group
Chemotherapy and Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With NeuroblastomaNCT00017225
Neuroblastoma
filgrastim
carboplatin
cisplatin
cyclophosphamid...
dacarbazine
doxorubicin hyd...
etoposide
ifosfamide
melphalan
tretinoin
vincristine sul...
vindesine
autologous bone...
conventional su...
peripheral bloo...
radiation thera...
- 20 YearsNational Cancer Institute (NCI)
Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the PeritoneumNCT00005860
Cancer
floxuridine
leucovorin calc...
oxaliplatin
18 Years - National Cancer Institute (NCI)
Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With NeuroblastomaNCT00004188
Neuroblastoma
filgrastim
carboplatin
cisplatin
cyclophosphamid...
doxorubicin hyd...
etoposide
isotretinoin
melphalan
topotecan hydro...
vincristine sul...
autologous bone...
bone marrow abl...
conventional su...
peripheral bloo...
radiation thera...
- 30 YearsChildren's Oncology Group
Biomarkers in Blood and Tissue Samples From Patients With Newly Diagnosed NeuroblastomaNCT01387724
Neuroblastoma
RNA analysis
polymerase chai...
protein express...
proteomic profi...
western blottin...
enzyme-linked i...
immunohistochem...
laboratory biom...
liquid chromato...
mass spectromet...
1 Year - 10 YearsChildren's Oncology Group
Combination Chemotherapy and Surgery With or Without Radiation Therapy in Treating Patients With Stage 2 or Stage 3 NeuroblastomaNCT00416676
Neuroblastoma
carboplatin
cisplatin
cyclophosphamid...
etoposide
vincristine sul...
adjuvant therap...
conventional su...
neoadjuvant the...
radiation thera...
1 Year - National Cancer Institute (NCI)
Combination Chemotherapy With or Without Filgrastim Before Surgery, High-Dose Chemotherapy, and Radiation Therapy Followed by Isotretinoin With or Without Monoclonal Antibody in Treating Patients With NeuroblastomaNCT00030719
Neuroblastoma
filgrastim
monoclonal anti...
busulfan
carboplatin
cyclophosphamid...
etoposide
isotretinoin
melphalan
vincristine sul...
bone marrow abl...
conventional su...
peripheral bloo...
radiation thera...
1 Year - 20 YearsNational Cancer Institute (NCI)
Monoclonal Antibody 3F8 and GM-CSF in Treating Young Patients With High-Risk, Refractory or Relapsed NeuroblastomaNCT00450307
Neuroblastoma
monoclonal anti...
sargramostim
- 21 YearsMemorial Sloan Kettering Cancer Center
Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With NeuroblastomaNCT00026312
Localized Resec...
Localized Unres...
Recurrent Neuro...
Regional Neurob...
Stage 4 Neurobl...
Stage 4S Neurob...
Aldesleukin
Dinutuximab
Isotretinoin
Laboratory Biom...
Pharmacological...
Quality-of-Life...
Sargramostim
- 30 YearsNational Cancer Institute (NCI)
Observation of Young Patients With Localized Neuroblastoma Who Have Undergone Surgery OnlyNCT00416559
Long-term Effec...
Neuroblastoma
clinical observ...
- 20 YearsNational Cancer Institute (NCI)
Combination Chemotherapy Followed by Stem Cell Transplant and Isotretinoin in Treating Young Patients With High-Risk NeuroblastomaNCT00526318
Neuroblastoma
filgrastim
carboplatin
cisplatin
cyclophosphamid...
dacarbazine
doxorubicin hyd...
etoposide phosp...
ifosfamide
isotretinoin
melphalan
topotecan hydro...
vincristine sul...
vindesine
autologous hema...
iobenguane I 13...
radiation thera...
- 21 YearsNational Cancer Institute (NCI)
Observation of Young Patients With Localized Neuroblastoma Who Have Undergone Surgery OnlyNCT00416559
Long-term Effec...
Neuroblastoma
clinical observ...
- 20 YearsNational Cancer Institute (NCI)
Combination Chemotherapy Followed by Surgery and Peripheral Stem Cell or Bone Marrow Transplantation in Treating Infants With Newly Diagnosed NeuroblastomaNCT00025649
Neuroblastoma
filgrastim
busulfan
carboplatin
cyclophosphamid...
doxorubicin hyd...
etoposide
melphalan
vincristine sul...
autologous bone...
conventional su...
peripheral bloo...
- 1 YearNational Cancer Institute (NCI)
Biological Therapy in Treating Patients With Neuroblastoma That Has Not Responded to Previous TreatmentNCT00089258
Neuroblastoma
beta-glucan
monoclonal anti...
sargramostim
isotretinoin
- Memorial Sloan Kettering Cancer Center
R(+)XK469 in Treating Patients With Advanced NeuroblastomaNCT00028522
Disseminated Ne...
Localized Unres...
Recurrent Neuro...
Regional Neurob...
R(+)XK469
5 Years - 20 YearsNational Cancer Institute (NCI)
Vorinostat and Isotretinoin in Treating Patients With High-Risk Refractory or Recurrent NeuroblastomaNCT01208454
Localized Unres...
Recurrent Neuro...
Regional Neurob...
Stage 4 Neurobl...
Stage 4S Neurob...
Isotretinoin
Laboratory Biom...
Pharmacological...
Vorinostat
- 30 YearsNational Cancer Institute (NCI)
Study of DNA in Blood Samples From Patients With NeuroblastomaNCT00898391
Disseminated Ne...
Localized Resec...
Localized Unres...
Recurrent Neuro...
Regional Neurob...
Stage 4S Neurob...
laboratory biom...
polymerase chai...
polyacrylamide ...
DNA analysis
- Children's Oncology Group
Carboplatin and Vincristine Plus Radiation Therapy Followed By Adjuvant Chemotherapy in Treating Young Patients With Newly Diagnosed CNS Embryonal TumorsNCT00003203
Brain Tumors
Central Nervous...
Neuroblastoma
filgrastim
carboplatin
cisplatin
cyclophosphamid...
vincristine sul...
adjuvant therap...
radiation thera...
3 Years - 21 YearsChildren's Oncology Group
Induction Chemotherapy Using Cyclophosphamide and Topotecan in Treating Patients Who Are Undergoing Autologous Peripheral Stem Cell Transplantation for Newly Diagnosed or Progressive NeuroblastomaNCT00070200
Neuroblastoma
filgrastim
cisplatin
cyclophosphamid...
doxorubicin hyd...
etoposide
isotretinoin
melphalan
topotecan hydro...
vincristine sul...
conventional su...
peripheral bloo...
radiation thera...
- 30 YearsChildren's Oncology Group
Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid TumorsNCT00003926
Brain and Centr...
Childhood Germ ...
Chordoma
Kidney Cancer
Liver Cancer
Neuroblastoma
Ovarian Cancer
Retinoblastoma
Sarcoma
amifostine trih...
busulfan
filgrastim
melphalan
thiotepa
peripheral bloo...
1 Year - 45 YearsMasonic Cancer Center, University of Minnesota
Combination Chemotherapy With or Without Radiation Therapy in Treating Children With Brain TumorsNCT00281905
Brain and Centr...
Neuroblastoma
carboplatin
cisplatin
cyclophosphamid...
methotrexate
vincristine sul...
radiation thera...
- 3 YearsNational Cancer Institute (NCI)
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed NeuroblastomaNCT00017368
Neuroblastoma
filgrastim
sargramostim
carboplatin
cisplatin
cyclophosphamid...
doxorubicin hyd...
etoposide
etoposide phosp...
ifosfamide
isotretinoin
melphalan
thiotepa
vincristine sul...
conventional su...
peripheral bloo...
radiation thera...
- 30 YearsChildren's Oncology Group
Studying Biomarkers in Samples From Patients With High-Risk NeuroblastomaNCT01510600
Neuroblastoma
DNA analysis
polymerase chai...
laboratory biom...
medical chart r...
- 30 YearsChildren's Oncology Group
Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid TumorsNCT00003926
Brain and Centr...
Childhood Germ ...
Chordoma
Kidney Cancer
Liver Cancer
Neuroblastoma
Ovarian Cancer
Retinoblastoma
Sarcoma
amifostine trih...
busulfan
filgrastim
melphalan
thiotepa
peripheral bloo...
1 Year - 45 YearsMasonic Cancer Center, University of Minnesota
Chemotherapy, Radiation Therapy, Immunotherapy, and Bone Marrow Transplantation in Treating Patients With NeuroblastomaNCT00002634
Neuroblastoma
filgrastim
monoclonal anti...
cisplatin
cyclophosphamid...
doxorubicin hyd...
etoposide
mesna
perfosfamide
vincristine sul...
autologous bone...
in vitro-treate...
low-LET cobalt-...
low-LET photon ...
radioisotope th...
1 Year - Memorial Sloan Kettering Cancer Center
Biomarkers in Young Patients With NeuroblastomaNCT01169376
Neuroblastoma
DNA analysis
DNA methylation...
RNA analysis
comparative gen...
mutation analys...
polymorphism an...
- 30 YearsChildren's Oncology Group
Combination Chemotherapy With or Without Filgrastim Before Surgery, High-Dose Chemotherapy, and Radiation Therapy Followed by Isotretinoin With or Without Monoclonal Antibody in Treating Patients With NeuroblastomaNCT00030719
Neuroblastoma
filgrastim
monoclonal anti...
busulfan
carboplatin
cyclophosphamid...
etoposide
isotretinoin
melphalan
vincristine sul...
bone marrow abl...
conventional su...
peripheral bloo...
radiation thera...
1 Year - 20 YearsNational Cancer Institute (NCI)
N2007-03: Vorinostat and 131-I MIBG in Treating Patients With Resistant or Relapsed NeuroblastomaNCT01019850
Neuroblastoma
Vorinostat
131- I Metaiodo...
Peripheral Bloo...
Filgrastim
2 Years - 30 YearsNew Approaches to Neuroblastoma Therapy Consortium
N99-01: Combination Chemotherapy, Radiation Therapy, and Stem Cell Transplantation in Treating Patients With NeuroblastomaNCT00005978
Neuroblastoma
filgrastim
carboplatin
etoposide
melphalan
autologous bone...
peripheral bloo...
iobenguane I 13...
radiation thera...
1 Year - 21 YearsNew Approaches to Neuroblastoma Therapy Consortium
Beta-Glucan and Monoclonal Antibody 3F8 in Treating Patients With Metastatic NeuroblastomaNCT00492167
Neuroblastoma
beta-glucan
monoclonal anti...
immunohistochem...
laboratory biom...
0 Years - 120 YearsMemorial Sloan Kettering Cancer Center
Chemotherapy and Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With NeuroblastomaNCT00017225
Neuroblastoma
filgrastim
carboplatin
cisplatin
cyclophosphamid...
dacarbazine
doxorubicin hyd...
etoposide
ifosfamide
melphalan
tretinoin
vincristine sul...
vindesine
autologous bone...
conventional su...
peripheral bloo...
radiation thera...
- 20 YearsNational Cancer Institute (NCI)
Beta-Glucan and Monoclonal Antibody 3F8 in Treating Patients With Metastatic NeuroblastomaNCT00492167
Neuroblastoma
beta-glucan
monoclonal anti...
immunohistochem...
laboratory biom...
0 Years - 120 YearsMemorial Sloan Kettering Cancer Center
Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for CancerNCT01132547
Cancer
cyproheptadine ...
placebo
2 Years - 21 YearsUniversity of South Florida
Biological Therapy in Treating Patients With Neuroblastoma That Has Not Responded to Previous TreatmentNCT00089258
Neuroblastoma
beta-glucan
monoclonal anti...
sargramostim
isotretinoin
- Memorial Sloan Kettering Cancer Center
N2007-03: Vorinostat and 131-I MIBG in Treating Patients With Resistant or Relapsed NeuroblastomaNCT01019850
Neuroblastoma
Vorinostat
131- I Metaiodo...
Peripheral Bloo...
Filgrastim
2 Years - 30 YearsNew Approaches to Neuroblastoma Therapy Consortium
Combination Chemotherapy Followed by Stem Cell Transplant and Isotretinoin in Treating Young Patients With High-Risk NeuroblastomaNCT00526318
Neuroblastoma
filgrastim
carboplatin
cisplatin
cyclophosphamid...
dacarbazine
doxorubicin hyd...
etoposide phosp...
ifosfamide
isotretinoin
melphalan
topotecan hydro...
vincristine sul...
vindesine
autologous hema...
iobenguane I 13...
radiation thera...
- 21 YearsNational Cancer Institute (NCI)
N99-02: Melphalan and Buthionine SulfoximineNCT00005835
Neuroblastoma
buthionine sulf...
melphalan
Peripheral bloo...
Filgrastim
- 30 YearsNew Approaches to Neuroblastoma Therapy Consortium
Monoclonal Antibody 3F8 and Sargramostim in Treating Patients With NeuroblastomaNCT00072358
Neuroblastoma
anti-GD2 murine...
anti-GD2 murine...
- Memorial Sloan Kettering Cancer Center
Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other MalignancyNCT00716976
Brain Tumor
Central Nervous...
Childhood Germ ...
Extragonadal Ge...
Liver Cancer
Neuroblastoma
Ototoxicity
Ovarian Cancer
Sarcoma
sodium thiosulf...
examination
1 Year - 18 YearsChildren's Oncology Group
Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or GanglioneuroblastomaNCT00904241
Ganglioneurobla...
Localized Resec...
Localized Unres...
Regional Neurob...
Stage 4 Neurobl...
Stage 4S Neurob...
Cytology Specim...
Laboratory Biom...
- 30 YearsChildren's Oncology Group
Combination Chemotherapy or Observation Following Surgery in Treating Infants With NeuroblastomaNCT00002803
Neuroblastoma
cyclophosphamid...
doxorubicin hyd...
vincristine sul...
conventional su...
- 1 YearNational Cancer Institute (NCI)
High-Dose Iodine I 131 Metaiodobenzylguanidine, Topotecan, and Peripheral Stem Cell Transplant in Treating Young Patients With Relapsed Stage 4 Neuroblastoma or Primary Resistant High-Risk NeuroblastomaNCT00389766
Neuroblastoma
iodine I 131 me...
topotecan hydro...
chemotherapy
peripheral bloo...
radioisotope th...
radionuclide im...
radiosensitizat...
total-body irra...
1 Year - 17 YearsNational Cancer Institute (NCI)
Ethanol-Lock Treatment in Preventing Central Venous Catheter Infections in Patients With High-Risk NeuroblastomaNCT00471679
Neuroblastoma
ethanol
- Memorial Sloan Kettering Cancer Center
Monoclonal Antibody Therapy With Sargramostim and Interleukin-2 in Treating Children With NeuroblastomaNCT00005576
Disseminated Ne...
Recurrent Neuro...
Regional Neurob...
monoclonal anti...
isotretinoin
aldesleukin
sargramostim
- 21 YearsNational Cancer Institute (NCI)
Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Primitive Neuroectodermal TumorsNCT00003846
Brain and Centr...
Neuroblastoma
filgrastim
carboplatin
cyclophosphamid...
thiotepa
vincristine sul...
bone marrow abl...
peripheral bloo...
radiation thera...
3 Years - 21 YearsChildren's Oncology Group
Combination Chemotherapy Followed By Surgery With or Without Radiation Therapy in Treating Young Patients With Stage II or Stage III NeuroblastomaNCT00276731
Neuroblastoma
carboplatin
cisplatin
cyclophosphamid...
etoposide
vincristine sul...
conventional su...
neoadjuvant the...
radiation thera...
1 Year - National Cancer Institute (NCI)
Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma Who Are Undergoing Surgery With or Without Autologous Bone Marrow or Peripheral Stem Cell TransplantNCT00417053
Neuroblastoma
filgrastim
busulfan
carboplatin
cyclophosphamid...
doxorubicin hyd...
etoposide phosp...
melphalan
vincristine sul...
autologous bone...
bone marrow abl...
conventional su...
peripheral bloo...
radiation thera...
- 1 YearNational Cancer Institute (NCI)
Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain TumorNCT00003273
Brain and Centr...
Neuroblastoma
Retinoblastoma
Sarcoma
filgrastim
carboplatin
cisplatin
cyclophosphamid...
etoposide
leucovorin calc...
methotrexate
temozolomide
thiotepa
vincristine sul...
autologous bone...
peripheral bloo...
radiation thera...
- 10 YearsNYU Langone Health
Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With IsotretinoinNCT01175356
Ganglioneurobla...
Localized Resec...
Localized Unres...
Regional Neurob...
Stage 4 Neurobl...
Stage 4S Neurob...
3-Dimensional C...
Autologous Hema...
Busulfan
Cisplatin
Cyclophosphamid...
Doxorubicin Hyd...
Etoposide Phosp...
External Beam R...
In Vitro-Treate...
Intensity-Modul...
Iobenguane I-13...
Isotretinoin
Laboratory Biom...
Melphalan
Pharmacological...
Questionnaire A...
Therapeutic Con...
Topotecan Hydro...
Vincristine Sul...
1 Year - 30 YearsChildren's Oncology Group
Monoclonal Antibody 3F8 and Sargramostim in Treating Patients With NeuroblastomaNCT00072358
Neuroblastoma
anti-GD2 murine...
anti-GD2 murine...
- Memorial Sloan Kettering Cancer Center
Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Primitive Neuroectodermal TumorsNCT00003846
Brain and Centr...
Neuroblastoma
filgrastim
carboplatin
cyclophosphamid...
thiotepa
vincristine sul...
bone marrow abl...
peripheral bloo...
radiation thera...
3 Years - 21 YearsChildren's Oncology Group
Biomarkers in Samples From Young Patients With NeuroblastomaNCT01358604
Neuroblastoma
polymerase chai...
protein express...
western blottin...
flow cytometry
immunohistochem...
laboratory biom...
- 120 YearsChildren's Oncology Group
Study of Specimens From Young Patients With NeuroblastomaNCT00958659
Localized Resec...
Localized Unres...
Regional Neurob...
Stage 4S Neurob...
laboratory biom...
- 18 YearsChildren's Oncology Group
R(+)XK469 in Treating Patients With Advanced NeuroblastomaNCT00028522
Disseminated Ne...
Localized Unres...
Recurrent Neuro...
Regional Neurob...
R(+)XK469
5 Years - 20 YearsNational Cancer Institute (NCI)
Study of Specimens From Young Patients With NeuroblastomaNCT00958659
Localized Resec...
Localized Unres...
Regional Neurob...
Stage 4S Neurob...
laboratory biom...
- 18 YearsChildren's Oncology Group
Genetic Analysis Using Blood or Bone Marrow From Participants With Neuroblastoma or Noncancerous ConditionsNCT00436696
Localized Resec...
Localized Unres...
Recurrent Neuro...
Regional Neurob...
Stage 4 Neurobl...
Laboratory Biom...
- Children's Oncology Group
Biomarkers in Samples From Young Patients With NeuroblastomaNCT01358604
Neuroblastoma
polymerase chai...
protein express...
western blottin...
flow cytometry
immunohistochem...
laboratory biom...
- 120 YearsChildren's Oncology Group
Combination Chemotherapy Followed by Surgery and Peripheral Stem Cell or Bone Marrow Transplantation in Treating Infants With Newly Diagnosed NeuroblastomaNCT00025649
Neuroblastoma
filgrastim
busulfan
carboplatin
cyclophosphamid...
doxorubicin hyd...
etoposide
melphalan
vincristine sul...
autologous bone...
conventional su...
peripheral bloo...
- 1 YearNational Cancer Institute (NCI)
N99-02: Melphalan and Buthionine SulfoximineNCT00005835
Neuroblastoma
buthionine sulf...
melphalan
Peripheral bloo...
Filgrastim
- 30 YearsNew Approaches to Neuroblastoma Therapy Consortium
Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Primitive Neuroectodermal TumorsNCT00003846
Brain and Centr...
Neuroblastoma
filgrastim
carboplatin
cyclophosphamid...
thiotepa
vincristine sul...
bone marrow abl...
peripheral bloo...
radiation thera...
3 Years - 21 YearsChildren's Oncology Group
Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk NeuroblastomaNCT00567567
Localized Resec...
Localized Unres...
Recurrent Neuro...
Regional Neurob...
Stage 4 Neurobl...
Stage 4S Neurob...
Autologous Hema...
Carboplatin
Cisplatin
Cyclophosphamid...
Doxorubicin Hyd...
Etoposide
External Beam R...
Filgrastim
Isotretinoin
Laboratory Biom...
Melphalan
Peripheral Bloo...
Pharmacological...
Thiotepa
Topotecan Hydro...
Vincristine Sul...
- 30 YearsChildren's Oncology Group
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: